
Mazdutide 10mg Metabolism
Dual GLP-1/glucagon agonist.
The dual agonist almost nobody stocks in France yet. Mazdutide acts on two receptors at once, GLP-1 and glucagon, where most compounds in this family target only one. Lyophilised powder, to be reconstituted. Store in the fridge, before and after reconstitution. Research material, not for human consumption.
- In stock in France
Ordered with its water: shipped in a magnetic box
10% off every deliveryPause, skip or cancel in 1 clickNo commitment, no hidden fees
No automatic charge: pay for each delivery by card, in Bitcoin (an extra 5% off), or by bank transfer from €100
Your complete kit
The vial alone cannot be used as is. Add what you need to prepare it:
Research Use Only (RUO) · Prohibited for human or veterinary use.
Key facts
Mazdutide (IBI362, LY3305677) is a synthetic peptide of 4563 g/mol, an analogue of oxyntomodulin. It activates two receptors at once: the GLP-1 receptor and the glucagon receptor. A fatty-acid chain grafted onto a lysine extends its lifetime in the blood. This vial contains 10 mg of it, lyophilised.
Most compounds in this family target the GLP-1 receptor onlyMazdutide adds the glucagon pathway. For laboratory research use only.
Protocol and preparation
| Water added | Concentration | Reading marker |
|---|---|---|
| 1 ml | 10 mg/ml | 10 UI = 1 mg |
| 2 ml | 5 mg/ml | 40 UI = 2 mg |
The volume of water does not change the product, only its concentration. Introduce the water slowly along the vial wall, never directly onto the lyophilisate, then swirl without shaking. Markers given on a 1 ml syringe graduated in 100 units.
Asepsis
Disinfect surfaces and stoppers (70% alcohol).
Solvent
Draw the required volume of bacteriostatic water.
Introduction
Inject gently against the vial wall (avoid direct jet on powder).
Solubilization
Roll the vial gently. Do not shake vigorously (degradation risk).
Solution storage Once reconstituted: 2-8°C (refrigerator).
Warning Theoretical tool for chemical handling. Does not constitute medical advice.
Open the dilution calculator- The amount of powder looks tiny. A lyophilisate takes up a few millimetres at the bottom of the vial, sometimes just a translucent film. The stated weight is there.
- The powder is compact, stuck to the wall or to the stopper. Transport moves the freeze-dried cake around. It changes nothing to reconstitution.
- The vial carries no individual label. That is our standard packaging, not a downgraded vial.
- After reconstitution, deposits or filaments appear. This is common, especially with small molecules. Let it settle and roll the vial between your palms, never shake it.
- The parcel is plain. Nothing on the outside indicates the contents or the brand name.
What is not normal: a cracked vial, an uncrimped cap or a stopper that moves, powder that has liquefied or changed colour. In those specific cases, write to us with a photo and we take the vial back.
Technical data
- Reconstitution
- 1 ml d'eau → 10 mg/ml. 20 UI = 2 mg ; 40 UI = 4 mg ; 60 UI = 6 mg.
- Peptide sequence
- HXQGTFTSDYSKYLDEKKAKEFVEWLLEGGPSSG (X = Aib ; lysine acylée)
- Molecular formula
- C210H322N46O67
- Molecular weight
- 4563.07 g/mol
- CAS number
- 2259884-03-0
- Physical form
- Poudre lyophilisée blanche
- Recommended solubility
- Eau bactériostatique, NaCl 0.9%, acide acétique 0.1%
- Storage conditions
- Au réfrigérateur (+2 à +8 °C), à l'abri de la lumière. En poudre, possible au congélateur pour une conservation longue. Une fois préparé : réfrigérateur, jamais au congélateur.
- Use
- Research reagent, in vitro only (RUO)
Storage & handling
Unreconstituted vial. Refrigerated, between +2 and +8 °C, protected from light. A freezer (-20 °C) is suitable for long-term storage.
After reconstitution. Refrigerator only, protected from light, never the freezer.
The 10 mg vial is reconstituted with 1 ml of bacteriostatic water, i.e. 10 mg/ml.
Mechanism of action
The GLP-1 receptor and the glucagon receptor are both Gs-coupled receptors: their activation raises cyclic AMP in the cell. The first is carried notably by pancreatic beta cells and by neurons of the brainstem and hypothalamus; the second, mostly by hepatocytes.
Oxyntomodulin, a natural gut hormone, already activates both receptors, but it is degraded within minutes. Mazdutide reproduces this dual profile in a stabilised molecule: a non-natural amino acid (Aib) at position 2 protects it from the DPP-4 enzyme, and its fatty-acid chain binds it to plasma albumin.
Studies and references
Mazdutide is developed by Innovent Biologics, under licence from Eli Lilly. Its phase 3 trial GLORY-1 (NCT05607680), conducted in adults in China over 48 weeks with weekly administration, was published in the New England Journal of Medicine in 2025. China's medicines agency (NMPA) authorised it the same year: it is the first dual GLP-1/glucagon agonist to be authorised.
These trials concern the manufacturer's medicine, not this vial. The product sold here is a laboratory reagent, for research use only.
